An open-label, randomised, phase 3 trial to evaluate the efficacy and safety of AztreonanLYsine for inhalation versus Tobramycin nebuliser solution in an intermittent aerosolized antibiotic regimen in patients with cystic fibrosis. - ND An open-label, randomised, phase 3 trial to evaluate the efficacy and safety of AztreonanLYsinefor ...
An open-label, randomised, phase 3 trial to evaluate the efficacy and safety of AztreonanLYsine for inhalation versus Tobramycin nebuliser solution in an intermittent aerosolized antibiotic regimen in patients with cystic fibrosis. - ND An open-label, randomised, phase 3 trial to evaluate the efficacy and safety of AztreonanLYsinefor ...